Cargando…
Activatable photothermal agents with target-initiated large spectral separation for highly effective reduction of side effects
Photothermal agents (PTAs) with minimized side effects are critical for transforming cancer photothermal therapy (PTT) into clinical applications. However, most currently available PTAs lack true selective activation to reduce side effects because of heavy spectral overlap between photothermal agent...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400798/ https://www.ncbi.nlm.nih.gov/pubmed/36128038 http://dx.doi.org/10.1039/d2sc02467e |